We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$101B
AUM Growth
+$2.01B
Cap. Flow
-$3.82B
Cap. Flow %
-3.77%
Top 10 Hldgs %
21.46%
Holding
3,342
New
87
Increased
1,934
Reduced
957
Closed
183

Top Buys

Rank Stock Value
1
VALE icon
Vale
VALE
+$90.8M
2
CMCSA icon
Comcast
CMCSA
+$75.5M
3
MELI icon
Mercado Libre
MELI
+$72.9M
4
DHR icon
Danaher
DHR
+$51M
5
PWR icon
Quanta Services
PWR
+$46.2M

Sector Composition

Rank Sector Weight
1 Technology 25.7%
2 Healthcare 15.68%
3 Financials 13.32%
4 Consumer Discretionary 9.98%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHN
3001
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$147K ﹤0.01%
14,000
WKME
3002
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$146K ﹤0.01%
+15,232
New +$148K
STOK icon
3003
Stoke Therapeutics
STOK
$1.84B
$144K ﹤0.01%
+13,511
New +$144K
LAW icon
3004
CS Disco
LAW
$261M
$138K ﹤0.01%
+16,761
New +$115K
LBC
3005
DELISTED
Luther Burbank Corporation Common Stock
LBC
$135K ﹤0.01%
15,145
+4,643
+44% +$42.1K
PAY icon
3006
Paymentus
PAY
$4.34B
$134K ﹤0.01%
+12,709
New +$119K
PNF
3007
DELISTED
PIMCO New York Municipal Income Fund
PNF
$133K ﹤0.01%
15,500
ORGO icon
3008
Organogenesis Holdings
ORGO
$301M
$133K ﹤0.01%
40,000
-44,248
-53% -$131K
NGM
3009
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$129K ﹤0.01%
49,704
+12,122
+32% +$43.2K
MYN icon
3010
BlackRock MuniYield New York Quality Fund
MYN
$372M
$124K ﹤0.01%
12,200
ERAS icon
3011
Erasca
ERAS
$6.19B
$123K ﹤0.01%
44,498
-34,924
-44% -$99.5K
VLD
3012
DELISTED
Velo3D, Inc.
VLD
$121K ﹤0.01%
1,604
+608
+61% +$42.4K
DNTH icon
3013
Dianthus Therapeutics
DNTH
$5.8B
$113K ﹤0.01%
9,331
-2,763
-23% -$31.4K
METCB icon
3014
Ramaco Resources Class B
METCB
$450M
$113K ﹤0.01%
+11,447
New +$110K
CZOO
3015
DELISTED
Cazoo Group Ltd
CZOO
$98.1K ﹤0.01%
831
IGMS
3016
DELISTED
IGM Biosciences
IGMS
$97.9K ﹤0.01%
10,607
-604
-5% -$6.77K
OBIO icon
3017
Orchestra BioMed
OBIO
$247M
$93.4K ﹤0.01%
+13,341
New +$202K
KC
3018
Kingsoft Cloud Holdings
KC
$3.56B
$93.1K ﹤0.01%
15,262
-3
-0% -$18
TUYA
3019
Tuya Inc
TUYA
$1.06B
$91.7K ﹤0.01%
+48,544
New +$93.3K
GMDA
3020
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$91.7K ﹤0.01%
47,500
API
3021
Agora
API
$344M
$54.5K ﹤0.01%
17,400
-3,576
-17% -$11.6K
VRM icon
3022
Vroom Inc
VRM
$37.2M
$51.6K ﹤0.01%
448
TIGR
3023
UP Fintech Holding
TIGR
$868M
$49K ﹤0.01%
17,271
DIBS icon
3024
1stdibs.com
DIBS
$149M
$48.6K ﹤0.01%
13,008
GOTU icon
3025
Gaotu Techedu
GOTU
$458M
$46.9K ﹤0.01%
16,219
+3,957
+32% +$12.5K

Similar funds

Credit Suisse's Q2 2023 Portfolio in Review

As of Q2 2023, Credit Suisse held 3,342 positions worth $101B, up 2% from $99.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Credit Suisse withdrew a net $3.82B in Q2 2023, closing 183 positions and reducing 957 holdings. Its most notable exit was Zai Lab, an estimated $73.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in ProShares UltraPro Short QQQ worth $4.03M.

  • Credit Suisse's largest Q2 2023 buy was ProShares UltraPro Short QQQ: 8,529 shares worth $4.03M.
  • Credit Suisse added most to Vale in Q2 2023, an estimated $90.8M increase.
  • Credit Suisse's biggest Q2 2023 reduction was Microsoft, cutting an estimated $323M.
  • Credit Suisse fully exited Zai Lab in Q2 2023, selling an estimated $73.2M.
  • Credit Suisse's ten largest holdings make up 21% of its $101B portfolio in Q2 2023.
  • Credit Suisse opened 87 new positions and closed 183 in Q2 2023.
  • Credit Suisse's portfolio value rose 2% quarter-over-quarter to $101B.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.